Omalizumab (an anti-IgE antibody) in the treatment of severe atopic eczema

Journal of Investigational Allergology and Clinical Immunology

Volumn 21, Issue 5, 2011, Pages 416-417

  Ramirez Del Pozo M E ^a   Contreras Contreras, E ^a   Lopez Tiro J ^a   Gomez Vera J ^a  

^a CENTRO MÉDICO NACIONAL 20 DE NOVIEMBRE   (Mexico)

Author keywords

Atopic dermatitis; Omalizumab; Quality of life; Scorad; Treatment

Indexed keywords

IMMUNOGLOBULIN E; OMALIZUMAB;

ABSENCE OF SIDE EFFECTS; ADULT; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; LABORATORY TEST; MALE; NOTE; PHYSICAL EXAMINATION; QUALITY OF LIFE; SCHOOL CHILD; SCORING SYSTEM;

ADOLESCENT; ADULT; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; CHILD; DERMATITIS, ATOPIC; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 80051760741     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Note

References (9)

1. Bieber T. Atopic dermatitis. N Engl J Med. 2008;358:1483-94
2. Méndez J. Alergia, Enfermedad Multisistémica. 1st edition. Mexico 2008. Ed. Panamericana.
3. Flores SG, Gómez VJ, Orea M, López TJ, Serrano E, Rodríguez A, Rodríguez A, Estrada S, N Jiménez N, Factor de Transferencia como inmunomodulador específico en el tratamiento de la Dermatitis Atópica moderada a severa. Alergia México. 2005; 52(6): 215-20.
4. Chisolm, S. Taylor SL, Balkrishnan R, Feldman SR. Written action plans: potential for improving outcomes in children with atopic dermatitis. J Am Acad Dermatol. 2008:59; 677-83.
5. Hamilton R. Accuracy of US Food and Drug Administration- cleared IgE antibody assays in the presence of anti-IgE (Omalizumab). J Allergy Clin Immunol. 2008;47:59-66.
6. Finlay AY, Khan GK. Dermatology life quality Index (DLQI); a simple practical measure for routine clinical use. Clin Exp Dermatol 1994:19;210-16.
7. Vigo PG, Girgis KR, Pfuetze BL, Critchlow ME, Fisher J, Hussain I. efficacy of anti-IgE therapy in patients with atopic dermatitis. J Am Acad Dermatol.2006; 55(1):168-70.
8. Belloni B, Ziai M, Lim A. Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels. J Allergy Clin Immunol. 2007; 120:1223-1225.
9. Krathen RA, Hsu S. Failure of omalizumab for treatment of severe adult atopic dermatitis. J Am Acad Dermatol. 2005; 53: 338-40.